General MedicationsORALGeneric

ROSIGLITAZONE MALEATE AND METFORMIN HYDROCHLORIDE

METFORMIN HYDROCHLORIDE; ROSIGLITAZONE MALEATE

Standard Dose

500MG;EQ 2MG BASE

Max Dose

Refer to approved labeling

Primary Use

Marketing status: Discontinued

Summary

Approval overview ROSIGLITAZONE MALEATE AND METFORMIN HYDROCHLORIDE is listed in Drugs@FDA under application 077337 (ANDA).

Marketing status: Discontinued Active ingredient METFORMIN HYDROCHLORIDE; ROSIGLITAZONE MALEATE Form and strength TABLET;ORAL - 500MG;EQ 2MG BASE Sponsor TEVA Submission history Latest submission status date: 2017-05-19 00:00:00.

Structured Monograph

Clinical summary

Approval overview ROSIGLITAZONE MALEATE AND METFORMIN HYDROCHLORIDE is listed in Drugs@FDA under application 077337 (ANDA). Marketing status: Discontinued Active ingredient METFORMIN HYDROCHLORIDE; ROSIGLITAZONE MALEATE Form and strength TABLET;ORAL - 500MG;EQ 2MG BASE Sponsor TEVA Submission history Latest submission status date: 2017-05-19 00:00:00. Submission type: ORIG.

Monitoring

• Marketing status: Discontinued

Interaction Notes

No interaction notes stored yet.